—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Insmed Inc (INSM) — Technical state

As of 2026-11-04 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Signal: Downtrend stack — Trades -1.5% vs the 50-day and -11.7% vs the 200-day average, 48.3% below the 52-week high and +21.7% off the 52-week low. Computed from daily closes. (as of 2026-11-04)
  • Trend: Insmed Inc trades 1.5% below its 50-day and 11.7% below its 200-day moving average. (as of 2026-11-04)

Insmed develops and sells medicines for serious and rare diseases, with commercial operations across the United States, Europe and Japan. Its approved product, Arikayce, treats a rare lung infection, and it is advancing brensocatib through late-stage trials for bronchiectasis and related inflammatory conditions.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the INSM overview. Research diary readings, not advice.

Downtrend stack

Trades -1.5% vs the 50-day and -11.7% vs the 200-day average, 48.3% below the 52-week high and +21.7% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the INSM chart & overview · the signal board

FAQ · from the current data · as of 2026-11-04

Quick answers

What is the current Closelooknet signal on INSM?

Downtrend stack — Trades -1.5% vs the 50-day and -11.7% vs the 200-day average, 48.3% below the 52-week high and +21.7% off the 52-week low. Computed from daily closes. As of 2026-11-04; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is INSM above its 50-day and 200-day moving averages?

As of 2026-11-04, Insmed Inc trades -1.5% below its 50-day and -11.7% below its 200-day average, with the 20-day +10.2% away.

How far is INSM from its 52-week high?

48.3% below the 52-week high and 21.7% above the 52-week low, as of 2026-11-04.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.